검색
MoonLake Immunotherapeutics
MLTX관심 목록에 추가
18.937USD
-0.193-1.01%
시장 운영 시간 （ET）시세는 15분 지연됩니다
1.35B시가총액
손실P/E TTM
자세한 내용은 MoonLake Immunotherapeutics 회사
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
MoonLake Immunotherapeutics 정보
종목 코드 MLTX
회사 이름MoonLake Immunotherapeutics
상장일Oct 20, 2020
CEOSantos Da Silva (Jorge)
직원 수100
유형Ordinary Share
회계 연도 종료Oct 20
주소Dorfstrasse 29
도시ZUG
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Switzerland
우편 번호6300
전화41415108022
웹사이트https://moonlaketx.com/
종목 코드 MLTX
상장일Oct 20, 2020
CEOSantos Da Silva (Jorge)
MoonLake Immunotherapeutics의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.01M
+1.63%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.12M
-5.11%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Ms. Catherine Moukheibir
Ms. Catherine Moukheibir
Independent Director
Independent Director
--
--
Dr. Ramnik Xavier
Dr. Ramnik Xavier
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.01M
+1.63%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.12M
-5.11%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Ms. Catherine Moukheibir
Ms. Catherine Moukheibir
Independent Director
Independent Director
--
--
Dr. Ramnik Xavier
Dr. Ramnik Xavier
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
자주 묻는 질문
MoonLake Immunotherapeutics의 상위 5대 주주는 누구인가요?
MoonLake Immunotherapeutics의 상위 5대 주주는 다음과 같습니다: Dr. Kristian Reich
MoonLake Immunotherapeutics(MLTX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, MoonLake Immunotherapeutics의 주식을 보유한 기관은 총 358곳이며, 이들이 보유한 주식의 총 가치는 약 54.44M로 전체 발행 주식의 74.73%를 차지합니다. 이는 2025Q4 대비 -3151979.00 증가한 수치입니다.